Validation of the French Version of the OSA-18 Questionnaire

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07136909

Acronym

French OSA18

Enrollment

200

Registered

2025-08-22

Start date

2026-06-29

Completion date

2028-01-29

Last updated

2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea, Obstructive

Keywords

Obstructive sleep apnea, sleep disordered breathing, questionnaire

Brief summary

Obstructive sleep apnea (OSA) is characterized by repetitive partial and/or total closure of the upper airway during sleep, inducing oxygen desaturation and sleep disturbance. Its prevalence in the pediatric population is 1-5%. In children, OSA can have negative consequences on the cardiovascular system and on the neurocognitive development. It is essential to diagnose OSA and to treat it efficiently. The OSA-18 questionnaire assesses the symptômes of OSA in children and its repercussions. It is composed of 18 items scored on a Likert scale by caregivers. This system allows a more sensitive scoring than binary answers available in other questionnaires like the Pediatric Sleep Questionnaire. The OSA-18 questionnaire would thus be an interesting tool to use for evaluating treatment efficacy in interventional studies and in clinical practice. This questionnaire is not yet available in French. The main objective of this study is thus to evaluate the validity of a French version compared to the gold standard method to evaluate OSA: polysomnography.

Interventions

OTHERCompletion of the OSA-18 questionnaire by parents, during hospitalization planned as part of routine care.

Completion of the OSA-18 questionnaire by parents, during hospitalization planned as part of routine care.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

4 Years to 17 Years

Inclusion criteria

* Children hospitalized in the Clinical Epileptology, Sleep Disorders, and Child Functional Neurology Department for polysomnography to screen for OSA, * Aged 4 to 17 years inclusive.

Exclusion criteria

* Parents and/or children object to participation in the study. * Subjects participating in another intervention research study with an ongoing exclusion period.

Design outcomes

Primary

Measure	Time frame	Description
Scores on the French version of the OSA-18 questionnaire (total score)	Day 2	The OSA-18 questionnaire will be filled-in by caregivers.

Countries

France

Contacts

CONTACTPatricia FRANCO, MD

patricia.franco@chu-lyon.fr04 27 85 60 52

CONTACTAurore GUYON

aurore.guyon@chu-lyon.fr04 27 85 52 47

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026